Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Aug 19, 2015 (11 years ago)

Midazolam

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Stability data does not support expiry.

Cause type: Stability / shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency. All stability / shelf life recalls.

What was recalled

Midazolam (PF) 0.1 mg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total dosage 0.2 mg/ 2mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

Drug: Midazolam

Recalling firm
Pharmakon Pharmaceuticals
Origin
IN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0595-2016 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Midazolam recalls

See all
Class II · Moderate risk

midazolam in dextrose 5%

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-4036-1 D-1075-2023
Class II · Moderate risk

Midazolam Injection

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Ongoing Stability / shelf life Akorn, Inc. D-0859-2023

Other recalls by Pharmakon Pharmaceuticals

All 2015 recalls